XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net loss attributable to Agrify Corporation $ (148,551) $ (19,204)
Adjustments to reconcile net loss attributable to Agrify Corporation to net cash used in operating activities:    
Depreciation and amortization 2,602 508
Impairment on goodwill and intangible assets 69,904
Loss (gain) on extinguishment of notes payable, net 14,933 (2,685)
Change in fair value of warrant liability (5,686)
Amortization of premium on investment securities 606 522
Amortization of debt discount 1,990
Interest on investment securities (759) (574)
Provision for doubtful accounts 23,708
Provision for slow-moving inventory 967
Debt issuance costs paid (665)
Debt issuance costs amortized 389  
Deferred income taxes (262)
Compensation in connection with the issuance of stock options 3,538 4,007
Issuance of common shares in connection with acquisition 176
Non-cash interest (income) expense (1,522) 50
Loss from disposal of fixed assets 6 25
Change in fair value of contingent consideration (1,509)
Income attributable to non-controlling interests 5 153
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 1,217 (7,861)
Inventory (20,129) (5,227)
Prepaid expenses and other current assets (2,760) (3,523)
Prepaid and refundable taxes (10)
Right-of-use assets, net 55 62
Other non-current assets (1,275)
Accounts payable 378 7,906
Accrued expenses and other current liabilities (8,128) 7,367
Deferred revenue, net 4,843 741
Net cash used in operating activities (66,115) (17,557)
Cash flows from investing activities    
Purchases of property and equipment (8,002) (3,536)
Purchase of securities (283,271) (68,461)
Proceeds from the sale of securities 317,593
Issuance of loan receivables (26,942) (12,686)
Cash paid for business combination, net of cash acquired (3,513)
Net cash used in investing activities (4,135) (84,683)
Cash flows from financing activities    
Proceeds from issuance of debt and warrants in private placement 65,000
Proceeds from issuance of debt and warrants in private placement, net of fees 25,770
Proceeds from IPO, net of fees 56,961
Proceeds from Secondary public offering, net of fees 79,839
Proceeds from exercise of options 19 2,220
Proceeds from exercise of warrants 2 9
Proceeds from short-term loan payable 2,522
Repayment of debt and warrants in private placement (30,000)
Repayments of notes payable, other (2,685)  
Payments of financing leases (241) (154)
Net cash provided by financing activities 60,387 138,875
Net increase in cash and cash equivalents (9,863) 36,635
Cash and cash equivalents at the beginning of period 12,014 8,111
Cash and cash equivalents at the end of period 2,151 44,746
Cash, cash equivalents, and restricted cash at end of period    
Cash and cash equivalents 2,151 44,746
Restricted cash 10,000
Total cash, cash equivalents, and restricted cash at the end of period 12,151 44,746
Supplemental disclosures of non-cash investing activities    
Equipment sold for loan receivable to customer $ 289